Moderna Gets Fast-Track Status for RSV Vaccine
The FDA has given fast-track status to Moderna's mRNA vaccine against respiratory syncytial virus (RSV).
The FDA has given fast-track status to Moderna's mRNA vaccine against respiratory syncytial virus (RSV).